Table 1. Characteristics of subjects in study.
Number | Percent | |
---|---|---|
Gender (females) | 32/97 | 33 |
Age in years (mean ± SEM) | 51 ± 1.4 | |
History of aspirin sensitivity | 22/97 | 23 |
Physician diagnosed asthma | 59/97 | 61 |
No history of ASA sensitivity (AT) | History of ASA sensitivity (H-AS) | p-value | |
---|---|---|---|
Gender Females (%) |
22 of 75 (29) | 10 of 22 (45) | 0.19 |
Age (mean ± S.E) (yrs) | 52.5 ± 2 | 45.7 ± 3 | 0.04 |
Peripheral eosinophil count Pre-surgical, mean cells/cu. mm |
437 ± 38 | 463 ± 69 | 0.74 |
Peripheral eosinophil count Highest, mean cells/cu. mm |
574 ± 52 | 916 ± 94 | 0.002 |
Serum Vit. D lowest, mean ng/ml | 33.9 ± 2 | 25.7 ± 5 | 0.11 |
Serum IgE, Mean IU/l | 361 ± 87 | 371 ± 143 | 0.95 |
Allergen sensitivity by skin test (any) (%) | 35 (58) | 13 (70) | 0.41 |
Asthma (%) | 38 (50%) | 21 (95) | <0.001 |
Nasal polyps (%) | 60 (80) | 22 (100) | 0.01 |
Lund McKay Score CT sinus (total), presurgical | 13.7 ± 0.5 | 15.7 ± 1 | 0.06 |
Total SNOT-22 score pre-surgery | 39.6 ± 2 | 57.8 ± 4 | <0.001 |
Missing values: number of patients whose values were unavailable/missing. LM score (3), Eosinophil count (10), Vitamin D (44), IgE (30), allergen testing (20)